Insights on Clinical Trial Enrollment: Where we are as we head into 2022

As the pandemic continues to fluctuate, we look back at 2021 to assess the continued impact of the pandemic on clinical trial enrollment to help the industry navigate the dynamic landscape as we continue through 2022. This report highlights granular trial enrollment insights across therapeutic areas (oncology, immunomodulation, central nervous system (CNS), cardiovascular) and geographic regions (North America, Europe, Asia).

Request Free!

Comments are closed.